Lisata Therapeutics Inc. (LSTA) support and resistance · rev $1.0M
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
This page maps Lisata Therapeutics Inc. (LSTA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LSTA revenue for 2024-12-31 was $1.0M. Net income was -$20.0M. LSTA currently screens at market cap $31.7M.
LSTA currently screens at market cap $31.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LSTA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LSTA quote page for the session range and the stock page for the full model.
Not investment advice.